ARPEGE

ARPEGE

Presentation of the platform and its facility

ARPEGE : Presentation

The platform ARPEGE is dedicated to extensive analysis of the structural and functional features of protein complexes. It allows the characterization of all kinds of specific interactions either between ligand and target, protein partners, and signaling complexes.

Equipment

The available equipment includes a selection of the most efficient and sensitive plate readers adapted to luminescence analyses in medium-throughput format.

Techniques

Using a wide variety of advanced analysis techniques (BRET, FRET, TR-FRET…), it is possible to perform multiple cell-based assays in order to extensively analyze protein target features like ligand-binding, receptor dimerization, second messengers production or protein phosphorylation.

Formation

The platform’s staff organizes many communication operations and scientific workshops.

ARPEGE : Team

With its experience and know-how, our team is at your service to best meet your needs and your scientific projects.

Using a wide variety of advanced analysis techniques (BRET, FRET, TR-FRET…), it is possible to perform multiple cell-based assays in order to extensively analyze protein target features like ligand-binding, receptor dimerization, second messengers production or protein phosphorylation.

Scientific manager

Laurent Prézeau, DR

+33 (0)4 34 35 92 96

Exhibit 221b

Technical manager

Damien Maurel, IR

+33 (0)4 34 35 93 13

Exhibit 219

Engineer

Isabelle Brabet, IE

+33 (0)4 34 35 93 13

Exhibit 219

Engineer

Claire Vol, IE

+33 (0)4 34 35 93 13

Exhibit 219

ARPEGE : Quality

In order to meet your expectation and needs, the ARPEGE platform (Pharmacology Screening Interactome) of Montpellier is engaged in a quality approach with the aim to fulfil the requirements of the standard ISO 9001 : version 2015.

In this context, a satisfaction survey is sent each year to ARPEGE platform users in order to know their opinions and suggestions regarding the services offered by the platform.

Our purpose is to provide innovative techniques and devices in order to meet your changing needs.

The ARPEGE platform has been approved to the following Quality Management System Standards : ISO 9001:2015 since 11/06/2023 until 10/06/2026.

The Quality Management System is applicable to : « Research, expertise, and services for Pharmacology-Screening-Interactom analysis, in the field of biology ».

ARPEGE : Organigramme

Direction de la plateforme Arpege

    Responsable Scientifique :

  • Laurent PREZEAU
    • (DR, CNRS, 30%)

    Responsable management qualité :

  • Damien MAUREL
    • (IR, INSERM, 15%)
+-

Comité de Direction

  • Isabelle BRABET
  • Damien MAUREL
  • Laurent PREZEAU
  • Claire VOL
+-

Comité d'orientation scientifique et technique

    Experts locaux :

  • Benoît BORDIGNON
    • (BCM, Montpellier)
  • Séverine CHAUMONT-DUBEL
    • (IGF, Montpellier)
  • Rémy SOUNIER
    • (IGF, Montpellier)
+-

Correspondant

  • Finances : Isabelle BRABET
  • Communication : Damien MAUREL
  • Ressources Humaines : Laurent PREZEAU
+-

Pharmacologie Criblage Interactome

    Responsable Technique :

  • Damien MAUREL (IR, INSERM, 85%)

    Personnel plateau permanent :

  • Isabelle BRABET (IE, CNRS, 45%)
  • Claire VOL (IE, CNRS, 80%)
+-

ARPEGE : ETC 2026

HERAULTSCREEN 2026 – ETC2026

Molecular Screening: Identify and characterize molecular probes and tools for therapeutic purposes

ARPEGE : For any request, contact us!